Abstract
The aim of the study was to assess the existence of possible associations among frequent polymorphisms in angiotensinogen genes and some of the risk factors for essential hypertension, especially body mass index (BMI) and smoking. A total of 192 control subjects (aged 45.87 ± 3.0 years) and 206 patients with the essential hypertension (aged 48.71 ± 8.42 years) were compared at three angiotensinogen gene polymorphisms by considering BMI and smoking status. No significant differences in genotype and/or allelic distribution for either A (-6) G ATG, M235T or T174M polymorphisms between the hypertensive and control groups were proved. Significantly more hypertensives than control persons with BMI above 25 kg/m2 were observed (Pcorr = 0.009), independently on sex distribution. A percentage of 44.6% of smokers in the control group vs 46.0% of smokers in the hypertensive groups were found. No significant difference in concurrence of BMI above 25 kg/m2 and positive smoking status between control and hypertensive subjects was found. Statistically significant differences were found between control and hypertensive subjects when compared distributions of subjects with certain genotypes of the three examined polymorphisms considering BMI (Pcorr = 0.0002 for AA+AG of A (-6) G ATG, Pcorr = 0.01 for CC+CT of T(174)M ATG and Pcorr = 0.01 for MT+TT of M235T ATG). No functional relationship among obesity and the examined polymorphisms in vivo are known. We conclude that a different distribution of BMI could influence the results of analyses of angiotensinogen gene polymorphisms in essential hypertension-control studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jeunemaitre X et al. Molecular basis of human hypertension: role of angiotensinogen Cell 1992; 1: 169–180
Jeunemaitre X et al. M235T variant of the angiotensinogen gene in unselected hypertensivepatients J Hypertens 1993; 11: 80–81
Bennett CL, Schrader AP, Moris BJ . Cross-sectional analysis of Met235 → Thr variant of angiotensinogen gene in severe familial hypertension Biochem Biophys Res Commun 1993; 197: 833–839
Caulfield M, Lavender P, Farrall M . Linkage of angiotensinogen gene to essential hypertension N Engl J Med 1994; 330: 1629–1633
Schmidt S et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset Nephrol Dial Transplant 1995; 10: 1145–1148
Fornage M, Turner ST, Sing CF, Boerwinkle E . Variation at the M235T locus of angiotensinogen gene and essential hypertension: a population-based case control study from Rochester, Minnesota Hum Genet 1995; 96: 295–300
Shunkert H et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort Hypertension 1997; 29: 628–633
Vašku A et al. Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension Kidney Int 1998; 53: 1479–1482
Horký J, Widimský J, Cífková R . Hypertenze. Bulletin České společnosti pro hypertenzi, 1/1998 Published by Astra Pharmaceutical s.r.o.: Praha, Czech Republic
Clamers J, Mancia G, van Zwieten PA (eds). ISH Hypertension News, 1/1999 Published by Publi Créations: Monaco
Sambrook J, FRITSCH EF, Maniatis T . Molecular Cloning: A Laboratory Manual, Second Edn, Book 2 Cold Spring Marbor Laboratory Press: NY 1989
Russ AP et al. Rapid detection of the hypertension-associated Met235 → Thr allele of human angiotensinogen gene Hum Mol Genet 1993; 2: 609–610
Hegele RA et al. −6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree J Mol Genet 1998; 43: 37–41
Vašku A et al. Polymorphisms in angiotensinogen gene [M235T and G(-6)A] in multifactorial diseases Pathophysiology 2001; 8: 113–118
Giacchetti G et al. Gene expression of angiotensinogen in adipose tissue of obesepatients Int J Obes Relat Metab Disord 2000; 24: S142–S143
Van Harmelen V et al. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity Int J Obes Metab Disord 2000; 24: 673–678
Dussere E, Moulin P, Vidal H . Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissue Biochim Biophys Acta 2000; 1500: 88–96
Van Harmelen V et al. Increased adipose angiotensinogen gene expression in human obesity Obes Res 2000; 8: 337–341
Umemura S . Plasma angiotensinogen concentrations in obesepatients Am J Hypertens 1997; 10: 629–633
Inoue I et al. A nucleotide substitution in the promoter of human angiotensinogen gene is associated with essential hypertension and affects basal transcription in vitro J Clin Invest 1997; 66: 1786–1797
Dominiczak AF, Connell JMC, Soubrier F . Molecular Genetics of Hypertension BIOS Scientific Publishers Limited: Oxford, UK 1999
Sethi AA et al. Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study Hypertension 2001; 37: 875–881
Rodriguez-Perez JC et al. Effects of angiotensinogen gene M235T and A (-6) G variants on blood pressure and other vascular risk factors in a Spanish population J Hum Hypertens 2000; 14: 789–793
Cooper R et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension J Mol Hypertens 1997; 11: 107–111
Acknowledgements
The study was supported by grants No. 306/96/0099 (Grant Agency of the Czech Republic), by grant VS 96097 “promotion of Research in Universities” and CEZ J07/98:141100002 from the Ministry of Education, Youth and Physical Education of the Czech Republic.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vašků, A., Souček, M., Tschöplová, S. et al. An association of BMI with A (-6) G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension. J Hum Hypertens 16, 427–430 (2002). https://doi.org/10.1038/sj.jhh.1001409
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001409